Estimands in Oncology Panel Discussion

May 26, 2020

Innovative Drug Development at a Glance - The Concepts, The Vision, & The Factors to Consider

May 26, 2020

Study Designs for Oncology and Rare Disease

May 18, 2020

Refocus Your Enrollment to the Subpopulation of Interest with ENRICH

May 18, 2020

Optimizing Market Access for Medical Devices

May 18, 2020

New Opportunities & Implications for the Future of Drug Development in Emerging Economies

May 11, 2020

Conducting Sample Size Reassessment with Time-to-event Endpoints

May 11, 2020

Phase 2 Dose-finding Studies with MCP and Modelling Techniques

May 1, 2020

A Clinician's Perspective on Cancer Drug Development

May 1, 2020

Transparent Machine Learning in Oncology

April 30, 2020

Ongoing Trials During COVID-19: Quantitative Strategies and Methodological Aspects

April 30, 2020

Adaptive Umbrella Trial Using MAMS Module

April 30, 2020

Key Design Considerations for Basket and Umbrella Trials

April 30, 2020

Designing Event-based Studies: Reduce Sample Size and Increase Predictability

April 30, 2020

COVID-19: Trials, Designs and Tools for Promising Results

April 30, 2020

Phase 1 Dose Escalation Trials with ESCALATE

April 30, 2020

Harness Patient Reported Outcomes

December 17, 2019
 

Adaptive Trials for Non-Statisticians

October 9, 2019
 

Resolving Prior-Data Conflict

August 28, 2019
 

New Drug Development Paradigm

July 24, 2019
 

Optimizing Drug Development with Model Informed Decision Making

May 1, 2019
 

Adaptive Dose-Finding Designs: Improving Drug Development Strategies

February 1, 2019
 

What's New in East 6.53F MCP Mod2C Population Enrichment 26 Program-Level Design

August 2, 2018
 

CDISC Webinar

April 12, 2018
 
All posts